InsidersTradesSigma
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Humer Franz B, Director. Director active across 3 companies, notably Allogene Therapeutics, Inc.. In total, 9 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €43k. Activity tracked since 10 June 2021. The latest transaction was disclosed on 5 December 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
9 of 9 declarations
Franz B. Humer is a Board Member at Allogene Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. Humer brings valuable expertise in the biopharmaceutical sector, which is essential for the company's development.